Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826

Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826

FromThe Fellow on Call: The Heme/Onc Podcast


Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826

FromThe Fellow on Call: The Heme/Onc Podcast

ratings:
Length:
20 minutes
Released:
Jun 14, 2023
Format:
Podcast episode

Description

This week’s episode is part 2 of 5 of a joint mini-series with our friends Two Onc Docs. In today’s episode, we recap the current treatment of classical hodgkin’s lymphoma and then dive into the the SWOG 1826 plenary session abstract from the ASCO 2023 annual meeting. We also cover the concept of “p-values” and what it means when trials say “the median was not reached.” Content: - A quick recap of the current standard of care for classical hodgkin's lymphoma- A review of the recent SWOG 1826 trial presented at ASCO 2023- A discussion about "p-values"- A discussion about what it means when "the median was not reached" Want to reach the abstract yourself? Click here: https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4?af=RHave you checked out Episode 1? See link here for this episode released by Two Onc Docs: https://podcasts.apple.com/us/podcast/updates-from-asco23-rectal-cancer-the-prospect-trial/id1616541733?i=1000616604349** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Jun 14, 2023
Format:
Podcast episode

Titles in the series (100)

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.